Hoesl Vanessa, Kempa Sally, Prantl Lukas, Ochsenbauer Kathrin, Hoesl Julian, Kehrer Andreas, Bosselmann Talia
Center of Plastic, Hand and Reconstructive Surgery, University Hospital Regensburg, 93053 Regensburg, Germany.
Faculty of Medicine, University of Regensburg, 93053 Regensburg, Germany.
J Clin Med. 2022 Jun 22;11(13):3583. doi: 10.3390/jcm11133583.
Background: The Laboratory Risk Indicator for Necrotizing Fasciitis score (LRINEC) is a simple tool used to support early diagnosis of Necrotizing Fasciitis (NF). The aim of this study was to investigate whether the LRINEC is suitable as a progression and prognosis parameter in patients with NF. Methods: In this retrospective study, laboratory data of 70 patients with NF were analyzed. The LRINEC was calculated for every patient at the time of hospital admission and postoperatively after surgical interventions. Furthermore, the LRINEC was examined as a prognostic factor for survival. Results: The overall lethality of our series was 20 out of 70 (28.6%). A highly significant LRINEC decrease was found for serial debridements. The largest decrease was observed after the first debridement. There was a significant difference between the initial LRINEC of deceased and surviving patients. A cut off value of >6.5 (7 LRINEC points) resulted in an optimal constellation of sensitivity (70%) and specificity (60%) to predict lethality in patients with NF. Conclusions: The LRINEC significantly decreases after surgical debridement. An initial LRINEC equal or greater than seven is an independent prognostic marker for lethality and can help to identify high-risk patients.
坏死性筋膜炎实验室风险指标(LRINEC)评分是用于支持坏死性筋膜炎(NF)早期诊断的一种简单工具。本研究的目的是调查LRINEC是否适合作为NF患者病情进展及预后的参数。方法:在这项回顾性研究中,分析了70例NF患者的实验室数据。在患者入院时及手术干预后的术后阶段计算每位患者的LRINEC。此外,将LRINEC作为生存的预后因素进行检测。结果:本系列患者的总死亡率为70例中的20例(28.6%)。连续清创后LRINEC有高度显著下降。首次清创后下降幅度最大。死亡患者与存活患者的初始LRINEC存在显著差异。>6.5(7个LRINEC分值)的截断值可产生预测NF患者死亡率的灵敏度(70%)和特异度(60%)的最佳组合。结论:手术清创后LRINEC显著下降。初始LRINEC等于或大于7是死亡的独立预后标志物,有助于识别高危患者。